Wednesday, 25 January 2012, 9:09 am Article: BusinessDesk
Kiwi pimple cream bursts into US market
Jan. 25 (BusinessDesk) – new Zealand’s DouglasPharmaceuticals has gained Food and Drug administrationapproval to sell its acne medication, isotretinoin, in theUnited States.
The West Auckland-based company willdispatch its first US orders next month and a consumerlaunch is expected in April or May, the company said in astatement. The US acne medication market is worth about $494million and the company has been trying to break into themarket for 10 years.
“It’s our biggest export productand is the market leader in Spain, Austria, Germany andMexico,” …